NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. — filing under Nasdaq ticker BRPA — submitted a Form 10-Q to the SEC on May 15, 2020, accession number 0001654954-20-005634. The entity originated as Big Rock Partners Acquisition Corp, a blank-check company that completed its initial public offering in 2018, with Big Rock Partners, LLC serving as sponsor. The SPAC focused its target search on the healthcare and biopharmaceutical sector. As of the filing date, the company remained in its business-combination phase, operating as a special purpose acquisition vehicle. For complete filings history, deal timelines, and sponsor data on BRPA and thousands of other SPACs, sign up for full access at SpacDesk.